Literature DB >> 3095604

Challenges for cost-effectiveness research.

M C Weinstein.   

Abstract

Mesh:

Year:  1986        PMID: 3095604     DOI: 10.1177/0272989X8600600402

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


× No keyword cloud information.
  12 in total

1.  Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery.

Authors:  Elena Losina; James Wright; Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2012-03-21       Impact factor: 5.284

2.  Discounting in cost-effectiveness analysis of healthcare programmes.

Authors:  D A Katz; H G Welch
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

3.  Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy.

Authors:  S F Hurley
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 4.  Costs of illness in cost-effectiveness analysis. A review of the methodology.

Authors:  T A Hodgson
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

5.  Diagnostic decision making.

Authors:  A Antczak-Bouckoms; J F Tulloch; A J Bouckoms; D Keith; P Lavori
Journal:  Anesth Prog       Date:  1990 Mar-Jun

Review 6.  On the dearth of philosophical contributions to medicine.

Authors:  M Yarborough
Journal:  Theor Med       Date:  1990-12

7.  A method to measure the costs of counseling for HIV prevention.

Authors:  R D Gorsky
Journal:  Public Health Rep       Date:  1996       Impact factor: 2.792

8.  Nonionic contrast media: economic analysis and health policy development.

Authors:  V Goel; R B Deber; A S Detsky
Journal:  CMAJ       Date:  1989-02-15       Impact factor: 8.262

Review 9.  Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.

Authors:  H L Tan
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

10.  Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach.

Authors:  U D Allen; S E Read
Journal:  Can J Infect Dis       Date:  1993-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.